Diabetes patients who stop GLP-1 drugs increase their heart risks

Heart Benefits Fade After You Stop Taking GLP-1 Drugs: Study

This study, published in BMJ Medicine, investigated what happens when people with Type 2 diabetes stop or interrupt their treatment with GLP-1 drugs.

Ending GLP-1 treatment can increase cardiovascular risks

Stopping GLP-1 drugs like Wegovy/Ozempic or Zepbound/Mounjaro may raise heart attack, stroke, and death risk, BMJ Medicine study finds. Read more here.

Stopping GLP-1s Increases Heart Risks

Diabetes patients who stop GLP-1 drugs can undo and potentially reverse the cardiovascular protection from these medications, resulting in an increased risk for heart attack and stroke.

Health Rounds: Diabetes patients who stop GLP-1 drugs increase their heart risks

Taking GLP-1 drugs for diabetes has been shown to lower the risk of adverse heart events, but a new analysis found that going off the medication – even for a few months – may increase the odds of...

Diabetes patients who stop GLP-1 drugs increase their heart risks

Taking GLP-1 drugs for diabetes has been shown to lower the risk of ​adverse heart events, but a new analysis found that going off the medication – even for a few months – may increase the ‌odds of heart attack, stroke or death.